Onward Medical N.V. (FRA:63E)

Market Cap	143.92M -37.3%
Revenue (ttm)	8.42M +210.1%
Net Income	-45.27M
EPS	-0.85
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	2.070
Previous Close	2.050
Day's Range	2.070 - 2.090
52-Week Range	2.050 - 4.875
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven move...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 137
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 63E

Financial Performance

In 2025, Onward Medical's revenue was 5.41 million, an increase of 211.33% compared to the previous year's 1.74 million. Losses were -41.79 million, 17.0% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error